Abstract: Mitigating a user interface display function of a modular energy system includes receiving formatted video data at a video data converter circuit, providing differential video signaling data to the display from the video data converter circuit, providing a copy of the differential video signaling data to a processor, and determining that the differential video signaling data is changing over time. Mitigating erroneous outputs from an isolated interface includes receiving a state of a first switch of a first footswitch coupled to a first comparator and a reference voltage coupled to the first comparator, receiving the state of the first switch coupled to the first duplicate comparator and the reference voltage coupled to the first duplicate comparator, comparing the output of the first comparator with the output of the first duplicate comparator, and determining activation or deactivation of a surgical instrument coupled to the controller based on the comparison.

Abstract: Several mitigation circuits are disclosed. An audio mitigation circuit includes an audio mitigation control module configured to read a unique tone identification embedded in a digital audio signal to identify a digital audio tone. A video mitigation circuit confirms video to be displayed by a user interface. Another audio mitigation circuit is configured to process super-audible tones in an audio signal to confirm an audio asset. The disclosure also describes various methods associated with the mitigation circuits.

Abstract: Aspects of the present disclosure are presented for systems and methods for identifying characteristics of a return pad in a monopolar electrosurgical system using contact quality monitoring (CQM) and near field communication (NFC) signals. In some aspects, resistance or impedance materials are sensed that may help identify what kind of return pad is being used, including what is the structure of the pad. In some aspects, NFC signals are used to identify characteristics of the return pad. In some aspects, the grounding or return pad may include two separate materials that form an interconnecting or interwoven mesh and both act as non-active electrodes when both contact the patient. A non-zero impedance may separate conductive lines connecting the two separate materials that may be analyzed to obtain a defining signature about that is linked to structural characteristics about the return pad.

Abstract: A Link Stacking Actuator is a scalable device that will contract or expand upon the application of rotational force. This rotational force is converted into linear force in contraction and this contraction can be released for expansion. Contraction and expansion are determined by the relative direction of rotational force applied. The device only generates linear force when contracting. Expansion is simply a relaxation of the device. The conversion of rotational force to contraction is achieved by mechanical stacking of interconnected links that fold or stack into a structure when rotational torsion is applied from a motor against a fixed mount-point or another counter-rotating motor. When used in oppositional pairs, these devices can be used to actuate hinged beams such as robotic arms, legs, and fingers. The device can also be used for direct lift applications when configured in multiple parallel sets.

Abstract: An Environmental Navigation Aid is provided, and can be a rechargeable, portable, handheld device that can convert environmental information, such as distance to a target object, into tactile values for presentation to a user's palm or fingers by way of a tactile feedback wheel. The nature of the target object composition can be factored into the behavior of the feedback wheel. The Environmental Navigation Aid can be paired with a wireless charging dock that can also serve as a homing beacon when the handheld device is pointed at the changing dock. Stand-alone homing beacons for additional orientation referencing tasks can be added to an Environmental Navigation Aid as a system. The Environmental Navigation Aid is designed to assist the blind in perception of the world around them.

Abstract: The invention features methods and compositions feature lapatinib and/or rapamycin for treating or preventing a cardiac condition induced by anthracycline treatment.

Abstract: The invention features methods and compositions feature lapatinib and/or rapamycin for treating or preventing a cardiac condition induced by anthracycline treatment.

Abstract: This invention overcomes the disadvantages of the prior art by providing a system and method for cryptographic communication that allows for the use of identical random number database structures located on the sending and receiving clients to randomly encode and decode messages based on encoded instructions on how to apply the database to encode and subsequently decode the underlying encoded message data, allowing for a secure and keyless transfer of message data between the sender and the recipient. Illustratively, an encoded message on a sending client with an appended header containing the filename, a unique synchronization block and instruction set with the method and starting point is encoded again to obscure the header. The message is transmitted and received by a receiving client and decoded, first by trial and error on the header portion to reveal the header, and then the remaining message data according to the revealed instruction set.

Abstract: The present invention provides therapeutic methods which employ one or more identifiable types of mammalian stem cells, and/or their progenitor progeny cells, and/or their lineage-committed descendant cells, and/or their partially-differentiated offspring cells—with or without completely differentiated cells—to treat living mammalian subjects afflicted with a clinically recognized form of cardiopathology. The identifiable cell types include embryonic stem cells and their offspring cells; as well as the presently identified types of adult stem cells and their various offspring cells; and also include recently identified alternative cell types which have functional stem cell properties. Among the clinical forms of cardiopathology which can be efficaciously treated using the present therapeutic methods are myocardial infarction, myocarditis, heart failure, and cardiac dysrhythmia.

Abstract: The present invention provides genetically altered mammalian embryonic stem cells, their living descendent progeny having an altered genomic DNA, and therapeutic methods using these cells for improving cardiac function in a living subject after myocardial infarction. The genetically altered embryonic stem and progenitor cells may be maintained in-vitro as a stable cell line; and transplanted as active, mitotic cells to an infarcted area of the myocardial using any surgical procedure. After transplantation at a chosen anatomic site within the heart of the subject, these genetically altered cells will differentiate in-site, cause a regeneration of myocardocytes, and will effect a marked improvement in cardiac function for the subject.

Abstract: The present invention is a method for markedly improving cardiac function and repairing heart tissue in a living mammalian subject after the occurrence of a myocardial infarction. The method is a surgical technique which introduces and implants mammalian embryonic stem cells into the infarcted area of the myocardium. After implantation, the embryonic stem cells form stable grafts and survive indefinitely within the infarcted area of the heart in the living host. The demonstrated beneficial effects of the method include a decreased infarcted area and improved cardiac function as assessed by hemodynamic and echocardiographic measurements.

Abstract: A method of agglomerating oil-containing steel mill waste includes the step of combining a first steel mill waste component with a second steel mill waste component to form a mixture. The first waste component includes substantially dry non-oily steel mill waste and the second waste component includes oil-containing steel mill waste. The first waste component and the second waste component are agglomerated.

Abstract: Oxytetracycline aqueous solutions, particularly for parenteral administration containing N-Methylpyrollidone as a solvent are disclosed.

Abstract: A flexible anti-skid material for application to various outdoor and indoor surfaces to produce a long lasting, low-cost, non-skid waterproof surface is formed of a smooth layer of paint adhered to one side of a flexible carrier material and one or more layers of paint each having particles of sand embedded therein adhered to the other side of the flexible carrier material, the anti-skid material being applied to desired surfaces with the use of an adhesive. A method of making the flexible anti-skid material includes coating a hard, smooth substrate with paint, placing a flexible carrier material on the coating of paint, coating the flexible carrier material with paint, distributing sand on the coating of paint, repeating the latter two steps to produce a desired thickness for the anti-skid material, allowing the anti-skid material to dry, and removing the substrate.